Author(s): Ruediger Hehlmann, Michael Lauseker, Susanne Saussele et. al. Abstract: S 424 Session topic: 8. Chronic myeloid leukemia – Clinical Background: The optimum initial treatment of chronic myeloid leukemia (CML) is unknown. Aims: CML-study IV was designed to confirm the International Randomized Study on Interferon (IFN) and STI571 (IRIS) and to...
Pro zobrazení tohoto obsahu je třeba být přihlášen.